Skip to main content
SLAS2024 Main banner
Sartorius Ad
Back

Amine Sadok, PhD

Amgen, California, United States

Amine graduated as an engineer from University of Carthage in Tunisia and obtained his Master and PhD in Oncology Pharmacology and Therapeutics from the University of Aix-Marseille in France. He joined the Institute of Cancer Research in London, initially as a Marie Curie fellow working on the identification of therapeutic opportunities to target Ras signaling in melanoma, and later joined the ICR Drug Discovery Unit to lead the Targeted Protein Degradation (TPD) program. This work led to the inception of Monte Rosa Therapeutics. Amine lead Monte Rosa Tx Discovery Technologies Platform build out efforts in Basel and Boston and was responsible for developing and executing a highly differentiated strategy to leverage the small Molecule Glue Degraders platform for the identification of new translational opportunities in Oncology, Immunology & Inflammation and Rare Diseases. More Recently, Amine took a leadership role in the Induced Proximity Platform at Amgen in Thousand Oaks California where he’s responsible for advancing the early discovery efforts through oversight of the IPP groups focused on Targeted Protein Degradation.


Disclosure information not submitted.

Presentation(s):